How Clomiphene Affects SHBG

While clomiphene blocks estrogen receptors at the pituitary (its desired PCT effect), it acts as a partial estrogen agonist at hepatic tissue. This stimulates hepatic sex hormone-binding globulin (SHBG) synthesis. Tamoxifen (20 mg/day) raises SHBG by approximately 20%, and clomiphene has a similar hepatic estrogenic effect. The elevated SHBG binds circulating testosterone with high affinity, reducing the bioavailable (free) fraction. This creates a discrepancy between total testosterone (which may appear normal) and free testosterone (which remains suppressed).

SHBG typically increases by 15-25% during clomiphene therapy at 25-50 mg/day. In men with already normal SHBG (30-40 nmol/L), this can push SHBG to 40-55 nmol/L. The effect develops over 2-4 weeks and persists throughout therapy. After stopping clomiphene, SHBG gradually returns toward baseline over 2-6 weeks.

Always order SHBG alongside total testosterone during and after PCT. Calculate free testosterone using the Vermeulen equation (total testosterone, SHBG, albumin). A free testosterone below the lab reference range despite "normal" total testosterone indicates the SHBG trap. Retest SHBG at 4-6 weeks after stopping clomiphene to confirm normalization.

The SHBG elevation from clomiphene is an expected pharmacological effect, not a complication requiring treatment. However, interpreting PCT success requires accounting for it. Do not declare recovery based on total testosterone alone while on SERMs. If free testosterone remains low after stopping clomiphene and SHBG has normalized, the issue is insufficient testosterone production, not SHBG binding. Consider extended PCT or endocrinology referral.